Showing results (131-140 of 332) with videos related to
Sort By:
Pageof 34
Neurology|May 29, 2026
Use of High-Efficacy Therapy in Children With Multiple Sclerosis to Prevent Long-Term DisabilitySifat Sharmin, Izanne Roos, Pierre M Labauge, et al.Journal of Central Nervous System Disease|August 11, 2021
Efficacy and Safety of Teriflunomide in Multiple Sclerosis across Age Groups: Analysis from Pooled Pivotal and Real-world StudiesJiwon Oh, Sandra Vukusic, Klaus Tiel-Wilck, et al.Brain : a Journal of Neurology|March 1, 2011
Tyrosine kinase 2 variant influences T lymphocyte polarization and multiple sclerosis susceptibilityNicolas Couturier, Florence Bucciarelli, Ramil N Nurtdinov, et al.The Lancet. Neurology|October 15, 2023
Radiologically isolated syndromeChristine Lebrun-Frenay, Orhun Kantarci, Aksel Siva, et al.Neurology and Therapy|November 29, 2021
Glial Fibrillary Acidic Protein (GFAP) Astrocytopathy Presenting as Mild Encephalopathy with Reversible Splenium LesionCharlotte Héraud, Nicolas Capet, Michaël Levraut, et al.Annals of Neurology|April 25, 2017
Multiple sclerosis broke my heartGéraldine Androdias, Emilien Bernard, Damien Biotti, et al.Archives of Neurology|May 12, 2010
Metabotropic glutamate receptor type 1 autoantibody-associated cerebellitis: a primary autoimmune disease?Romain Marignier, Florian Chenevier, Veronique Rogemond, et al.Multiple Sclerosis and Related Disorders|June 26, 2022
Ocrelizumab during pregnancy and lactation: Rationale and design of the MINORE and SOPRANINO studies in women with MS and their infantsRiley Bove, Kerstin Hellwig, Noemi Pasquarelli, et al.Multiple Sclerosis and Related Disorders|September 28, 2024
Alexithymia in radiologically isolated syndromeHéloise Joly, Emilie Gerbier, Margaux Zerlini, et al.Frontiers in Immunology|April 11, 2022
Kappa Free Light Chains, Soluble Interleukin-2 Receptor, and Interleukin-6 Help Explore Patients Presenting With Brain White Matter HyperintensitiesMichael Levraut, Cassandre Landes, Lydiane Mondot, et al.Pageof 34